GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Transcenta Holding Ltd (HKSE:06628) » Definitions » EV-to-FCF

Transcenta Holding (HKSE:06628) EV-to-FCF : -2.80 (As of Mar. 23, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Transcenta Holding EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Transcenta Holding's Enterprise Value is HK$857.38 Mil. Transcenta Holding's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2024 was HK$-306.13 Mil. Therefore, Transcenta Holding's EV-to-FCF for today is -2.80.

The historical rank and industry rank for Transcenta Holding's EV-to-FCF or its related term are showing as below:

HKSE:06628' s EV-to-FCF Range Over the Past 10 Years
Min: -22.93   Med: -1.18   Max: 0.92
Current: -2.06

During the past 5 years, the highest EV-to-FCF of Transcenta Holding was 0.92. The lowest was -22.93. And the median was -1.18.

HKSE:06628's EV-to-FCF is ranked worse than
100% of 424 companies
in the Biotechnology industry
Industry Median: 3.285 vs HKSE:06628: -2.06

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-03-23), Transcenta Holding's stock price is HK$2.00. Transcenta Holding's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was HK$-0.968. Therefore, Transcenta Holding's PE Ratio (TTM) for today is At Loss.


Transcenta Holding EV-to-FCF Historical Data

The historical data trend for Transcenta Holding's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Transcenta Holding EV-to-FCF Chart

Transcenta Holding Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
- - -5.53 -2.14 -3.46

Transcenta Holding Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only - -2.14 - -3.46 -

Competitive Comparison of Transcenta Holding's EV-to-FCF

For the Biotechnology subindustry, Transcenta Holding's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Transcenta Holding's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Transcenta Holding's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Transcenta Holding's EV-to-FCF falls into.



Transcenta Holding EV-to-FCF Calculation

Transcenta Holding's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=857.380/-306.125
=-2.80

Transcenta Holding's current Enterprise Value is HK$857.38 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Transcenta Holding's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2024 was HK$-306.13 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Transcenta Holding  (HKSE:06628) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Transcenta Holding's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=2.00/-0.968
=At Loss

Transcenta Holding's share price for today is HK$2.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Transcenta Holding's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was HK$-0.968.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Transcenta Holding EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Transcenta Holding's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Transcenta Holding Business Description

Traded in Other Exchanges
N/A
Address
B6-501, 218 Xinghu Street, Biobay, Suzhou, CHN, 215123
Transcenta Holding Ltd is a clinical-stage biopharmaceutical company with fully integrated capacities in discovery, research, development, and manufacturing. It is developing nine therapeutic antibody molecules for oncology and selected non-oncology indications including bone and kidney disorders. Geographically the company operates in China (the PRC) and the USA.
Executives
Qian Xueming 2101 Beneficial owner
Shi Xiaohong 2501 Other
Lav Corporate Gp, Ltd. 2201 Interest of corporation controlled by you
Lav Gp Iii, L.p. 2201 Interest of corporation controlled by you
Lav Biosciences Fund Iii, L.p. 2101 Beneficial owner
Shi Yi 2201 Interest of corporation controlled by you
Lav Asset Management (hong Kong) Limited 2102 Investment manager
Fullerton Management Pte Ltd
Temasek Life Sciences Private Limited
Tls Beta Pte. Ltd.
Hsbc Trust Company (delaware), N.a. 2301 Trustee
Success Link International L.p. 2101 Beneficial owner
Temasek Holdings (private) Limited
Lav Vitality Limited 2101 Beneficial owner
Zhong Guo Guo You Qi Ye Jie Gou Tiao Zheng Ji Jin Gu Fen You Xian Gong Si 2501 Other

Transcenta Holding Headlines

No Headlines